Merck (MRK) Total Current Liabilities (2009 - 2026)

Merck (MRK) has reported Total Current Liabilities for 18 consecutive years, with $27.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Current Liabilities rose 6.51% year-over-year to $27.7 billion in Q2 2026; TTM through Jun 2026 was $27.7 billion, a 6.51% increase from a year earlier, with the FY2025 full-year figure at $28.3 billion, changed 0.33% from the prior year.
• Total Current Liabilities was $27.7 billion for Q2 2026 at Merck, up from $26.9 billion in the prior quarter.
• Over five years, Total Current Liabilities peaked at $29.6 billion in Q3 2024 and troughed at $22.3 billion in Q1 2022.
• A 5-year average of $25.6 billion and a median of $25.4 billion in 2023 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities decreased 15.34% in 2022 and climbed 28.11% in 2024, its largest moves.
• Over 5 years, Total Current Liabilities stood at $24.2 billion in 2022, then gained by 6.0% to $25.7 billion in 2023, then increased by 10.61% to $28.4 billion in 2024, then retreated by 0.33% to $28.3 billion in 2025, then decreased by 2.1% to $27.7 billion in 2026.
• The last three Total Current Liabilities figures came in at $27.7 billion (Q2 2026), $26.9 billion (Q1 2026), and $28.3 billion (Q4 2025), per Business Quant data.